Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores

J Thromb Haemost. 2016 Sep;14(9):1711-4. doi: 10.1111/jth.13386. Epub 2016 Jul 27.

Authors

G Y H Lip^{1

2}, D A Lane^{3

4}

Affiliations

¹ University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Birmingham, UK. g.y.h.lip@bham.ac.uk.
² Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. g.y.h.lip@bham.ac.uk.
³ University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Birmingham, UK.
⁴ Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

PMID: 27296528
DOI: 10.1111/jth.13386

No abstract available

Publication types

Comment

MeSH terms

Anticoagulants
Atrial Fibrillation*
Hemorrhage*
Humans
Risk Assessment
Risk Factors
Stroke
Warfarin

Substances

Anticoagulants
Warfarin